NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 33 filers reported holding NRX PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $10,113 | +11.6% | 21,426 | +8.8% | 0.00% | – |
| Q4 2023 | $9,060 | +279.6% | 19,696 | +114.5% | 0.00% | – |
| Q3 2023 | $2,387 | -82.3% | 9,181 | -67.1% | 0.00% | – |
| Q2 2023 | $13,521 | +135110.0% | 27,936 | +88.2% | 0.00% | – |
| Q1 2023 | $10 | +42.9% | 14,842 | +143.2% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 6,102 | -52.8% | 0.00% | – |
| Q3 2022 | $10,000 | +400.0% | 12,936 | +219.2% | 0.00% | – |
| Q2 2022 | $2,000 | -84.6% | 4,053 | -21.1% | 0.00% | – |
| Q1 2022 | $13,000 | +1200.0% | 5,134 | +2244.3% | 0.00% | – |
| Q4 2021 | $1,000 | -90.0% | 219 | -78.7% | 0.00% | – |
| Q3 2021 | $10,000 | +900.0% | 1,026 | +683.2% | 0.00% | – |
| Q2 2021 | $1,000 | – | 131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 642,632 | $295,611 | 0.07% |
| One Wealth Management Investment & Advisory Services, LLC | 140,402 | $64,585 | 0.03% |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $29,113 | 0.00% |
| HighPoint Advisor Group LLC | 43,501 | $23,000 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $13,446 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $8,418 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 122,700 | $56,442 | 0.00% |
| NORTHERN TRUST CORP | 74,996 | $34,498 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 46,837 | $21,545 | 0.00% |